Authors’ reply to Schaffalitzky de Muckadell and colleague’s Comment on “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017”

Detalles Bibliográficos
Autores principales: Ehlken, Birgit, Nathell, Lennart, Gohlke, Annegret, Bocuk, Derya, Toussi, Massoud, Wohlfeil, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475511/
https://www.ncbi.nlm.nih.gov/pubmed/30937851
http://dx.doi.org/10.1007/s40264-019-00815-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475511/
https://www.ncbi.nlm.nih.gov/pubmed/30937851
http://dx.doi.org/10.1007/s40264-019-00815-4

Ejemplares similares